T. Rowe Price Associates’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Buy |
38,552
+6,390
| +20% | +$35K | ﹤0.01% | 2690 |
|
|
2025
Q1 | $203K | Buy |
32,162
+6,996
| +28% | +$44.2K | ﹤0.01% | 2630 |
|
|
2024
Q4 | $104K | Buy |
25,166
+6,119
| +32% | +$25.3K | ﹤0.01% | 2818 |
|
|
2024
Q3 | $64K | Hold |
19,047
| – | – | ﹤0.01% | 2896 |
|
|
2024
Q2 | $57K | Buy |
19,047
+5,486
| +40% | +$16.4K | ﹤0.01% | 2839 |
|
|
2024
Q1 | $47K | Buy |
+13,561
| New | +$47K | ﹤0.01% | 2879 |
|